Serra Capital III is very pleased to announce its first investment in Skylit Medical on April 21.
Skylit Medical is a connected device that uses cutting edge LED technology to bring personal, private prescription phototherapy to patients with psoriasis, eczema and vitiligo. According to third party research, 95% of physicians would prescribe Skylit Medical because they could maintain a relationship with their patients.
Skylit brings handheld, guided therapy to millions of patients, while staying wirelessly connected to physicians and dermatologists. Skylit Medical improves care by bringing convenient, low-cost therapy into a patient’s home.